Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

50.23
-16.3500-24.56%
Post-market: 50.470.2383+0.47%19:59 EDT
Volume:14.01M
Turnover:712.44M
Market Cap:6.19B
PE:13.36
High:57.99
Open:57.76
Low:48.10
Close:66.58
Loading ...
Jun 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities